Table 2.
Average | Control | ivTXA [n=43] | locTXA [n=41] | P-value [n=41] | |
---|---|---|---|---|---|
THA | Number | n=43 | n=41 | n=41 | |
Transfusion; no/yes, n (%) | 16 (37.2) / 27 (62.8) | 36 (87.8) / 5 (12.2) | 37 (90.2) / 4 (9.8) | <0.001 | |
Hospitalization days; mean±SD | 7.21±2.58 | 4.90±1.67 | 5.10±1.81 | <0.001 | |
Hgb max diff; mean±SD | -3.85±1.30 | -3.21±0.97 | -2.90±0.98 | <0.001 | |
TKA | Number | n=41 | n=41 | n=42 | |
Transfusion; no/yes, n (%) | 14 (34.1) / 27 (65.9) | 38 (92.7) / 3 (7.3) | 38 (90.5) / 4 (9.5) | <0.001 | |
Hospitalization days; mean±SD | 7.78±3.11 | 4.83±1.41 | 4.81±1.04 | <0.001 | |
Hgb max diff; mean±SD | -3.32±1.43 | -2.76±1.07 | -2.35±0.91 | 0.001 |
TKA, total knee arthroplasty; THA, total hip arthroplasty.